UNSPSC 51373401: Ammonium/bromodiphenhydramine/codeine/menthol/potassium

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373401 Ammonium/bromodiphenhydramine/codeine/menthol/potassium is a Commodity code covering pharmaceutical and controlled-substance products used in correctional and public-health settings. The work actually being solicited under this code spans parenteral products (intravenous solutions, parenteral nutrition preparations, and controlled substances for medically necessary healthcare) and harm-reduction pharmaceuticals such as naloxone. State and local buying bodies are issuing competitive solicitations — RFQQs and IFBs — for supplies to be delivered to correctional facilities, community health departments, and public health initiatives. Issuing bodies include state departments of corrections and county health or public-safety agencies. Bidders must meet stringent insurance requirements, maintain controlled-substance handling compliance, and demonstrate documented experience in preparation, delivery, and patient-monitoring protocols for pharmaceutical products. Set-aside programs appear in at least one recent solicitation: the Washington State Department of Corrections RFQ includes aspirational targets for small business (25%), minority-owned business (10%), women-owned business (6%), and veteran-owned business (5%) participation, and requires prime contractors to document qualified subcontractors including minority-owned and women-owned firms.

Recent activity spans Washington State and Florida. The Washington State Department of Corrections issued RFQ RFQQK13020 (posted September 8, 2026; due October 7, 2026) for parenteral products, services, and equipment to supply eight correctional facilities across three regions, with DOC anticipating awards to up to three bidders per region and an initial contract term running through June 30, 2030. Seminole County, Florida issued IFB 60459723LAS (posted June 30, 2026; due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the county community health building. The Washington solicitation emphasizes tight delivery windows (PN bags within 24 hours of order, other parenteral products within 8 hours) and fixed pricing for the initial two-year term; the Florida procurement specifies unit-cost bidding with a two-year initial term and one-year renewal option.